Mediterranean Diet and Gut Microbiota in Children With Systemic Lupus Erythematosus
NCT07555626 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2026-04-29
Summary
The goal of this clinical trial is to learn if a Mediterranean diet can improve gut microbiota, disease activity, and nutrition in children with systemic lupus erythematosus (SLE). The study will include children with SLE and healthy family members living in the same home.
The main questions it aims to answer are:
Does a Mediterranean diet improve gut microbiota in children with SLE? Does the diet help reduce disease activity? Does the diet improve overall nutrition? Researchers will compare children with SLE to healthy family members to better understand how diet, gut microbiota, and health are related.
Participants will:
Give stool samples at the beginning and end of the study to analyze gut microbiota.
Have body measurements taken. Record what they eat for 3 days (2 weekdays and 1 weekend day). Answer questions about their diet, physical activity, sleep, and health. Children with SLE in the intervention group will receive nutrition counseling based on the Mediterranean diet for 12 weeks. The counseling will focus on increasing foods rich in polyphenols and reducing processed foods to improve overall diet quality. They will also receive advice on physical activity.
At the end of the study, some participants will join a group discussion to share their experiences.
Conditions
- Systemic Lupus Erythematosus (SLE)
Interventions
- BEHAVIORAL
-
Mediterranean Diet-Based Individual Nutrition Counseling
Participants receive individualized nutrition counseling from a dietitian at Erciyes University Children Hospital, tailored to each participant. The program aims to improve adherence to the Mediterranean Diet, increase polyphenol intake, reduce the dietary inflammatory index(DII), and limit ultra-processed foods. Diet is assessed via 3-day food records and KIDMED(Mediterranean Diet Quality Index for children and adolescents) scores. Guidance is provided to improve dietary mistakes and increase physical activity(IPAQ, International Physical Activity Questionnaire). Weekly follow-ups monitor adherence. Additional assessments include stool samples, anthropometrics, PSQI (Pittsburgh Sleep Quality Index), CHAQ(Childhood Health Assessment Questionnaire), SLEDAI-2K(Systemic Lupus Erythematosus Disease Activity Index 2000), and SLICC/SDI(Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index). No food is provided; focus is on modifying existing habits.
Sponsors & Collaborators
-
TC Erciyes University
lead OTHER
Principal Investigators
-
ZEYNEP CAFEROGLU AKIN, PhD · Erciyes University, Faculty of Health Sciences, Department of Nutrition and Dietetics
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 8 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-06-30
- Primary Completion
- 2027-10-31
- Completion
- 2029-02-28
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Monogenic Lupus in Childhood Onset Systemic Lupus Erythematosus
NCT04532541 ·Status: RECRUITING
-
Systemic Lupus Erythematosus
NCT05984316 ·Status: RECRUITING ·Phase: NA
-
Psychoeducational Approach to Improve Health in Lupus
NCT00000417 ·Status: COMPLETED ·Phase: PHASE2
-
Drug Compliance and Affecting Factors in Juvenile Idiopathic Arthritis
NCT06000566 ·Status: COMPLETED
-
A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus
NCT05687526 ·Status: COMPLETED ·Phase: PHASE1
-
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
NCT05835310 ·Status: RECRUITING ·Phase: PHASE3
-
Respiratory Function, Physical Activity and Fatigue in SLE
NCT07193745 ·Status: COMPLETED
-
Omega-3 Supplementation in Systemic Lupus Erythematosus
NCT07393399 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of Co-enzyme Q10 on the Clinical Outcome of Pediatric Patients With Systemic Lupus Erythematosus
NCT07096557 ·Status: COMPLETED ·Phase: PHASE2
-
Psycho-social Consequences of Systemic Lupus Erythematosus
NCT03913754 ·Status: COMPLETED
-
Gynecological Symptoms and Health-related Quality of Life in Egyptian Women With SLE
NCT05230316 ·Status: UNKNOWN
-
Serologically Active, Clinically Stable Systemic Lupus Erythematosus
NCT00000421 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Curcumin on Systemic Lupus Erythematosus
NCT03953261 ·Status: TERMINATED ·Phase: PHASE2
-
Lupus Intervention for Fatigue Trial
NCT02653287 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Genomic Effects of Glucocorticoids in Patients With Systemic Lupus Erythematosus
NCT04233164 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Assessment of Lipid Profile in Juvenile Systemic Lupus Erythematosus
NCT06151990 ·Status: RECRUITING
-
Motivating Individuals With Lupus to Exercise
NCT05287581 ·Status: COMPLETED ·Phase: NA
-
UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients
NCT06737380 ·Status: RECRUITING ·Phase: PHASE1
-
A Pilot Study to Explore the Role of Gut Flora in Lupus
NCT04213690 ·Status: WITHDRAWN
-
Safety of Estrogens in Lupus: Birth Control Pills
NCT00000420 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study - Effect of Omega-3 on Systemic Lupus Erythematosus
NCT02021513 ·Status: COMPLETED ·Phase: PHASE2
-
Healthy Lifestyle Intervention in Patients with Systemic Lupus Erythematosus: the Living Well with Lupus Study
NCT04431167 ·Status: COMPLETED ·Phase: NA
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus
NCT03421184 ·Status: COMPLETED ·Phase: NA
-
A Safety and Tolerability Study of MEDI-570 in Systemic Lupus Erythematosus
NCT01127321 ·Status: TERMINATED ·Phase: PHASE1